Current status of kidney and pancreas transplantation in the United States, 1994–2003


  • Note on sources: The articles in this report are based on the reference tables in the 2004 OPTN/SRTR Annual Report, which are not included in this publication. Many relevant data appear in the figures and tables included here; other tables from the Annual Report that serve as the basis for this article include the following: Tables 2.2, 5.1, 5.2, 5.3, 5.4, 5.4a, 5.4b, 5.4c, 5.7a, 5.7c, 5.8b, 5.8c, 5.9a, 5.9b, 5.9c, 5.10b, 5.14, 6.1, 6.2, 6.3, 6.4, 6.9, 6.10, 6.12, 7.1, 7.2, 7.3, 7.4, 7.7, 7.9, 7.10, 7.12, 8.1, 8.2, 8.3, 8.4, 8.7, 8.9, 8.12, 8.13, and 8.14. All of these tables may be found online at

  • Funding: The Scientific Registry of Transplant Recipients (SRTR) is funded by contract number 231-00-0116 from the Health Resources and Services Administration (HRSA), US Department of Health and Human Services. The views expressed herein are those of the authors and not necessarily those of the US Government. This is a US Government-sponsored work. There are no restrictions on its use.

*Corresponding author: Gabriel M. Danovitch,


This article reviews the OPTN/SRTR data collected on kidney and pancreas transplantation during 2003 in the context of trends over the past decade. Overall, the transplant community continued to struggle to meet the increasing demand for kidney and pancreas transplantation. The number of new wait-listed kidney registrants under the age of 50 has remained relatively stable since 1994, but the number of new registrants aged 50 to 64 has doubled. However, there was only a 2.3% increase in the total number of kidney transplants performed in 2003. Expanded criteria donor kidneys made up 20% of all recovered kidneys and 16% of all transplants performed, compared with 15% in the prior year. In May 2003, new rules were implemented to promote equity in kidney organ allocation. These changes seem to have improved access for historically disadvantaged groups, though they have reduced the quality of HLA matching. The effects on long-term outcomes have yet to be measured. Although the majority of SPK recipients are white (82%), the percentage of simultaneous kidney-pancreas recipients who are African-American has increased from 9% in 2000 to 16% in 2003. The percentage of Hispanic/Latino recipients increased from 5% to 9% over the same period.